Home
>
National Drug Code (NDC)
>
Amlodipine Besylate and Benazepril Hydrochloride
Amlodipine Besylate and Benazepril Hydrochloride - 43063-232-30 - (amlodipine besylate and benazepril hydrochloride)
Drug Information of Amlodipine Besylate and Benazepril Hydrochloride
| Product NDC: | 43063-232 |
| Proprietary Name: | Amlodipine Besylate and Benazepril Hydrochloride |
| Non Proprietary Name: | amlodipine besylate and benazepril hydrochloride |
| Active Ingredient(s): | 10; 20 mg/1; mg/1 & nbsp; amlodipine besylate and benazepril hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Amlodipine Besylate and Benazepril Hydrochloride
| Product NDC: | 43063-232 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020364 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950303 |
Package Information of Amlodipine Besylate and Benazepril Hydrochloride
| Package NDC: | 43063-232-30 |
| Package Description: | 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-232-30) |
NDC Information of Amlodipine Besylate and Benazepril Hydrochloride
| NDC Code | 43063-232-30 |
| Proprietary Name | Amlodipine Besylate and Benazepril Hydrochloride |
| Package Description | 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-232-30) |
| Product NDC | 43063-232 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | amlodipine besylate and benazepril hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19950303 |
| Marketing Category Name | NDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE |
| Strength Number | 10; 20 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
